retatrutide wikipedia File:Retatrutide.png Retatrutide FDA Approval Timeline 2026-2028:

Severe abdominal pain that radiates to the back and does not stop deserves urgent attention, because pancreatitis is a labeled risk that requires prompt evaluation

The FDA and several state attorneys general have issued warnings that there are currently no FDA-approved generic GLP-1 injections and that marketing compounded versions as equivalent to Ozempic may violate consumer protection laws

Semaglutide GLP-1 is an innovative prescription medication that supports weight management by reducing your appetite and calorie intake

Even before it added compounded GLP-1s to its portfolio, Hims & Hers said in its fourth-quarter earnings report that it expects its weight loss program to bring in more than $100 million in revenue by the end of 2025